Researchers identified a blood-based metabolite ratio that predicts asthma exacerbations up to five years in advance. The ...

New blood-based metabolomics test predicts asthma attacks up to five years ahead, helping identify high-risk patients before ...

Researchers at Mass General Brigham and Karolinska Institutet have identified a new method to predict asthma exacerbations with a high degree of accuracy. The study is published in Nature ...

This technique could predict asthma attacks up to years in advance - One in 12 Americans are living with asthma ...

Asthma is a respiratory condition caused by inflammation and constriction (narrowing) of the airways. It can cause symptoms such as shortness of breath, coughing, or wheezing. Asthma is a long-term ...

Tezspire (tezepelumab-ekko) is a monthly injection used to treat severe asthma. It was approved by the FDA in 2021 for use in addition to other asthma controlling medicines in people 12 and older.